key: cord-0929597-smsi8kig
authors: Peiró, Concepción; Moncada, Salvador
title: Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
date: 2020-05-26
journal: Circulation
DOI: 10.1161/circulationaha.120.047297
sha: 285481ee2b9957a8a9a55375d14845f57c4cf39d
doc_id: 929597
cord_uid: smsi8kig

nan

Diagram representing the main metabolic pathways driven by angiotensinconverting enzyme (ACE) and angiotensinconverting enzyme-2 (ACE2) in the reninangiotensin system. The pharmacological targets for ACE inhibitors (ACEI) and angiotensin AT1 receptors blockers (ARB) are also shown. Ang indicates angiotensin.

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

Clinical characteristics of coronavirus disease 2019 in China

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Dr Peiró is supported by a grant from Plan Nacional de I+D (SAF2017-84776-R).

None.